Annual report
3079.TEDINET S100R5FJ
Period2022-04-01 → 2023-03-31
Filed2023-06-28
StandardJapan GAAP
ConsolidatedNo
Data checks13 of 13 passed
Key figures · 88
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥47.5bn | 2022-04-01 → 2023-03-31 | Standalone | Net sales |
| Revenue | ¥45.5bn | 2021-04-01 → 2022-03-31 | Standalone | Net sales |
| Revenue | ¥41.0bn | 2020-04-01 → 2021-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥44.7bn | 2019-04-01 → 2020-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥40.4bn | 2018-04-01 → 2019-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥1.3bn | 2022-04-01 → 2023-03-31 | Standalone | Operating income |
| Operating income | ¥1.3bn | 2021-04-01 → 2022-03-31 | Standalone | Operating income |
| Ordinary income | ¥1.4bn | 2022-04-01 → 2023-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥1.3bn | 2021-04-01 → 2022-03-31 | Standalone | Ordinary income |
| Profit before tax | ¥1.4bn | 2022-04-01 → 2023-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥1.3bn | 2021-04-01 → 2022-03-31 | Standalone | Income before income taxes |
| Net income | ¥936m | 2022-04-01 → 2023-03-31 | Standalone | Profit loss |
| Net income | ¥863m | 2021-04-01 → 2022-03-31 | Standalone | Profit loss |
| Net income | ¥572m | 2020-04-01 → 2021-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥792m | 2019-04-01 → 2020-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥974m | 2018-04-01 → 2019-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥23.6bn | at 2023-03-31 | Standalone | Assets |
| Total assets | ¥22.2bn | at 2022-03-31 | Standalone | Assets |
| Total assets | ¥20.6bn | at 2021-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥20.4bn | at 2020-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥18.6bn | at 2019-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥14.3bn | at 2023-03-31 | Standalone | Liabilities |
| Total liabilities | ¥13.6bn | at 2022-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥9.3bn | at 2023-03-31 | Standalone | Net assets |
| Net assets / equity | ¥8.6bn | at 2022-03-31 | Standalone | Net assets |
| Net assets / equity | ¥7.9bn | at 2021-03-31d | Standalone | Net assets |
| Net assets / equity | ¥7.6bn | at 2020-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥7.5bn | at 2019-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥8.6bn | at 2023-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥7.8bn | at 2022-03-31 | Standalone | Cash and deposits |
| Cash & equivalents | ¥8.6bn | at 2023-03-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥7.8bn | at 2022-03-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥6.5bn | at 2021-03-31d | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥5.2bn | at 2020-03-31d | Standalone | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥5.3bn | at 2019-03-31d | Standalone | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥1.5bn | 2022-04-01 → 2023-03-31 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.7bn | 2021-04-01 → 2022-03-31 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.7bn | 2020-04-01 → 2021-03-31d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.0bn | 2019-04-01 → 2020-03-31d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥290m | 2018-04-01 → 2019-03-31d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥477m | 2022-04-01 → 2023-03-31 | Standalone | Net cash provided by used in investment activities |
| Investing cash flow | −¥97m | 2021-04-01 → 2022-03-31 | Standalone | Net cash provided by used in investment activities |
| Investing cash flow | −¥217m | 2020-04-01 → 2021-03-31d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥362m | 2019-04-01 → 2020-03-31d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥195m | 2018-04-01 → 2019-03-31d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥245m | 2022-04-01 → 2023-03-31 | Standalone | Net cash provided by used in financing activities |
| Financing cash flow | −¥235m | 2021-04-01 → 2022-03-31 | Standalone | Net cash provided by used in financing activities |
| Financing cash flow | −¥274m | 2020-04-01 → 2021-03-31d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥747m | 2019-04-01 → 2020-03-31d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥910m | 2018-04-01 → 2019-03-31d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥90.21 | 2022-04-01 → 2023-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥83.56 | 2021-04-01 → 2022-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥55.6 | 2020-04-01 → 2021-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥75.56 | 2019-04-01 → 2020-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥88.46 | 2018-04-01 → 2019-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥90.04 | 2022-04-01 → 2023-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥83.33 | 2021-04-01 → 2022-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥55.5 | 2020-04-01 → 2021-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥30 | 2022-04-01 → 2023-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥25 | 2021-04-01 → 2022-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥24 | 2020-04-01 → 2021-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥24 | 2019-04-01 → 2020-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥24 | 2018-04-01 → 2019-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥894.19 | at 2023-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥828.27 | at 2022-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥767.76 | at 2021-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥735.76 | at 2020-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥689.18 | at 2019-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 39.4% | at 2023-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 38.6% | at 2022-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 38.5% | at 2021-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 37.1% | at 2020-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 40.0% | at 2019-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 10.5% | 2022-04-01 → 2023-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 10.5% | 2021-04-01 → 2022-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 7.4% | 2020-04-01 → 2021-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 10.5% | 2019-04-01 → 2020-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 13.1% | 2018-04-01 → 2019-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 10,780,000 | at 2023-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 10,780,000 | at 2022-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 10,780,000 | at 2021-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 11,280,000 | at 2020-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 11,280,000 | at 2019-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 319 | at 2023-03-31 | Standalone | Number of employees |
| Employees | 328 | at 2022-03-31 | Standalone | Number of employees |
| Employees | 330 | at 2021-03-31d | Standalone | Number of employees |
| Employees | 322 | at 2020-03-31d | Standalone | Number of employees |
| Employees | 302 | at 2019-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 17
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-04-01 → 2023-03-31 | ¥3.6bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-04-01 → 2023-03-31 | ¥3.6bn |
| Arrhythmia Businessreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥40.9bn |
| Arrhythmia Businessreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥40.9bn |
| Ischemia Businessreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥3.1bn |
| Ischemia Businessreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥3.1bn |
| —segment total | revenue | 2022-04-01 → 2023-03-31 | ¥43.9bn |
| —segment total | revenue external | 2022-04-01 → 2023-03-31 | ¥43.9bn |
| Total Of Reportable Segments And Otherssegment total | employees | at 2023-03-31 | 319 pure |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2021-04-01 → 2022-03-31 | ¥2.9bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2021-04-01 → 2022-03-31 | ¥2.9bn |
| Arrhythmia Businessreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥39.4bn |
| Arrhythmia Businessreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥39.4bn |
| Ischemia Businessreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥3.2bn |
| Ischemia Businessreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥3.2bn |
| —segment total | revenue | 2021-04-01 → 2022-03-31 | ¥42.6bn |
| —segment total | revenue external | 2021-04-01 → 2022-03-31 | ¥42.6bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 930
| Item | Context | Value | Unit |
|---|---|---|---|
| Net cash provided by used in operating activities (5-year summary) | Prior2YearDuration_NonConsolidatedMember | 1743161000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior1YearDuration_NonConsolidatedMember | 1687188000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | CurrentYearDuration_NonConsolidatedMember | 1484945000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior4YearDuration_NonConsolidatedMember | -195215000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior3YearDuration_NonConsolidatedMember | -362299000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior2YearDuration_NonConsolidatedMember | -217122000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YearDuration_NonConsolidatedMember | -97487000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | CurrentYearDuration_NonConsolidatedMember | -477057000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior4YearDuration_NonConsolidatedMember | -909686000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior3YearDuration_NonConsolidatedMember | -746822000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior2YearDuration_NonConsolidatedMember | -273640000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YearDuration_NonConsolidatedMember | -235334000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | CurrentYearDuration_NonConsolidatedMember | -244917000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior4YearInstant_NonConsolidatedMember | 5298179000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior3YearInstant_NonConsolidatedMember | 5232708000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior2YearInstant_NonConsolidatedMember | 6486000000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1YearInstant_NonConsolidatedMember | 7846380000 | JPY |
| Cash and cash equivalents (5-year summary) | CurrentYearInstant_NonConsolidatedMember | 8614223000 | JPY |
| Number of employees | Prior4YearInstant_NonConsolidatedMember | 302 | |
| Number of employees | Prior3YearInstant_NonConsolidatedMember | 322 | |
| Number of employees | Prior2YearInstant_NonConsolidatedMember | 330 | |
| Number of employees | Prior1YearInstant_NonConsolidatedMember | 328 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember | 319 | |
| Average number of temporary workers | Prior4YearInstant_NonConsolidatedMember | 26 | |
| Average number of temporary workers | Prior3YearInstant_NonConsolidatedMember | 26 | |
| Average number of temporary workers | Prior2YearInstant_NonConsolidatedMember | 23 | |
| Average number of temporary workers | Prior1YearInstant_NonConsolidatedMember | 20 | |
| Average number of temporary workers | CurrentYearInstant_NonConsolidatedMember | 23 | |
| Total shareholder return | Prior4YearInstant_NonConsolidatedMember | 0.775 | |
| Total shareholder return | Prior3YearInstant_NonConsolidatedMember | 0.758 | |
| Total shareholder return | Prior2YearInstant_NonConsolidatedMember | 0.900 | |
| Total shareholder return | Prior1YearInstant_NonConsolidatedMember | 0.897 | |
| Total shareholder return | CurrentYearInstant_NonConsolidatedMember | 0.895 | |
| Total return on share price index | Prior4YearInstant_NonConsolidatedMember | 0.950 | |
| Total return on share price index | Prior3YearInstant_NonConsolidatedMember | 0.859 | |
| Total return on share price index | Prior2YearInstant_NonConsolidatedMember | 1.221 | |
| Total return on share price index | Prior1YearInstant_NonConsolidatedMember | 1.246 | |
| Total return on share price index | CurrentYearInstant_NonConsolidatedMember | 1.318 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember | 319 | |
| Average number of temporary workers | CurrentYearInstant_NonConsolidatedMember | 23 | |
| Average age years information about reporting company information about employees | CurrentYearInstant_NonConsolidatedMember | 38.6 | |
| Average length of service years information about reporting company information about employees | CurrentYearInstant_NonConsolidatedMember | 8.2 | |
| Average annual salary information about reporting company information about employees | CurrentYearInstant_NonConsolidatedMember | 6360000 | JPY |
| Number of employees | CurrentYearInstant_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember | 319 | |
| Average number of temporary workers | CurrentYearInstant_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember | 23 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember | 319 | |
| Average number of temporary workers | CurrentYearInstant_NonConsolidatedMember | 23 | |
| Research and development expenses research and development activities | CurrentYearDuration | 15426000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration | 269239000 | JPY |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 10780000 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 13 of 13 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |